Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience

BACKGROUND: Massive bleeding is one of the commonest salvageable causes of death. The search for an ideal haemostatic agent during massive bleeding is still ongoing. One of the novel haemostatic medications is recombinant activated factor VII (rFVIIa). To date, the usage of rFVIIa during massive hae...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Hematol
Главные авторы: Shah, Nurfatin Mohd, Chong, Soon Eu, Yusoff, Syahirah Mohamed, Mazlan, Mohd Zulfakar, Johan, Khairul Bariah, Azman, Nizuwan, Lim, Jo Anne, Mohamad, Siti Mardhiana, Noordin, Siti Salmah, Ghaffar, Zainab Abdul, Hassan, Mohd Hasyizan, Zabidi, Muhammad Azrul, Rahim, Nur Arzuar Abdul
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251212/
https://ncbi.nlm.nih.gov/pubmed/30498571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12878-018-0126-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы